https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Heart-MP.jpg

Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | Europe | 2020-2026 | MedSuite | Includes: Coronary Atherectomy Devices, Catheters (IVUS, OCT, Diagnostic, Balloon, Interventional), Guidewires (Diagnostic, Interventional), Stents, Introducer Sheaths, Vascular Closure & CEP Devices

  • Year: 2020
  • Scope: 2016-2026
  • Region: Europe
  • Pages: 513
  • Published Date: 11/30/2020
  • Type: MedSuite

In 2020, the European interventional cardiology market size was valued at approximately €928 million, down from nearly €1.2 billion in 2019 due to the impact of COVID-19. The European market size is expected to decrease over the forecast period and reach €1 billion in 2026.

Over 50% of the European interventional cardiology market share was occupied by Boston Scientific, Abbott, and Medtronic. Overall, this market research includes an analysis of 46 interventional cardiology companies spawning across more than 15 countries in Europe.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Interventional Cardiology Procedure Volumes in Europe
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each EU Interventional Cardiology Market Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Interventional Cardiology Market in Europe
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

COVID19 Impact on EU Interventional Cardiology Market

Due to COVID19, the European Interventional Cardiology market size declined by almost 27% from 2019, resulting in a valuation of approximately €928 million in 2020. The market size is expected to return to pre-COVID19 levels in 2022.

In March 2020, millions of patients had their care delayed as hospitals canceled non-urgent operations, including some surgeries for people with heart and lung conditions. The purpose of postponing non-essential elective surgeries and medical procedures was to conserve medical resources for COVID-19-related and life-threatening cases. Since this announcement, cardiovascular procedures were severely impacted. While PCI procedures are still considered urgent in treating acute myocardial infarction (MI), or heart attacks, only a small proportion of PCI procedures performed on patients were for these life-threatening conditions. The rest of the PCI procedures are categorized as “elective procedures” and were avoided or deferred during the pandemic.

EU Interventional Cardiology Market Insights

Technologies such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed. Prices for these image-guided devices are much higher than traditional interventional devices, resulting in upwards pressure on market value.

EU Interventional Cardiology Market Size by Segment, 2016-2026

The growth of image-guided devices for interventional cardiology, such as OCT and IVUS catheters, is heavily dependent on the annual volume of diagnostic and interventional catheterization procedures performed. Both PCI and angiography procedures are expected to exhibit flat growth over the forecast period, outside of COVID-19-related fluctuations. The rising demand for effective diagnostic cardiovascular imaging techniques is one of the factors resulting in greater adoption of IVUS devices.

EU Interventional Cardiology Market Share Insight

In 2020, the European Interventional Cardiology market share was dominated by three companies – Boston Scientific, Abbot, and Medtronic.

EU Interventional Cardiology Market Share Leaders

Boston Scientific was the leading competitor in the European market for interventional cardiology devices in 2020. The company was the leader of several segments, including coronary stents, balloon catheters, embolic protection devices, and atherectomy devices.

Abbott was the second-leading competitor in the European Interventional cardiology device market. The company led the interventional coronary guidewire, diagnostic coronary catheter and guidewire and coronary OCT catheter markets. Abbot greatly expanded its presence in the European market through its acquisition of St. Jude Medical in 2017.

Olympus was the second-leading competitor in the market in 2020. The company, as the number one manufacturer of endoscopes in the world, used its trusted and established brand name to capture a portion of the video endoscopy market in Europe. Olympus’ position is primarily attributable to its strong share of the surgical camera system market.

RESEARCH REGIONAL COVERAGE

Throughout this research series, iData Research has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The countries covered are:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Scandinavia (Norway, Finland, Sweden, and Denmark)
  • Switzerland
  • Austria
  • Portugal

Detailed Market Segmentation

While this MedSuitereport contains all of the EU Interventional Cardiology Devices market analysis and data, each of the market segments is also available as stand-alone MedCore reports.

  • Coronary Stent Market – MedCore – The market is further broken down into segments by:
    • Device Type: Bare-Metal Stents, and Drug-Eluting Stents.
  • Coronary Balloon Catheter Market – MedCore – The market is also further segmented by
    • Device Type: PTCA Balloon, Specialty Balloon, and Drug-Eluting Balloon catheters.
  • Coronary Atherectomy Device Market – MedCore – This analysis of the market is further broken down by:
    • Device Type: Laser and Mechanical Atherectomy device markets.
  • Introducer Sheath Market – MedCore – This market is further broken down by:
    • Device Type: Femoral and Radial Introducer Sheaths.
  • Coronary Vascular Closure Device (VCD)  Market – MedCore – The market analysis is further segmented by:
    • Device Type: Femoral and Radial Closure Devices.
  • Diagnostic Coronary Catheter & Guidewire Market – MedCore – The analysis is broken down by:
    • Device Type: Diagnostic Coronary Catheter, Diagnostic Coronary Guidewire, and Fractional Flow Reserve Guidewire markets.
  • Interventional Coronary Catheter Market – MedCore – The interventional catheters are used to place devices, such as stents and balloons, and are analyzed on a unit-basis within this European report.
  • Interventional Coronary Guidewire Market – MedCore – Interventional guidewires are often the first device type to cross an arterial lesion, and they are analyzed in-depth within this market research.
  • Coronary Embolic Protection Device Market – MedCore – The research includes an in-depth analysis of the Coronary Embolic Protection Device market.
  • Coronary Intravascular Ultrasound (IVUS) Market – MedCore – This European market research takes a closer look at the fast-growing Coronary IVUS device market.
  • Coronary Optical Coherency Tomography Market – MedCore – In-depth analysis of the Coronary Optical Coherency Tomography market in Europe.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS FOR EUROPEAN INTERVENTIONAL CARDIOLOGY REPORT SUITE

TABLE OF CONTENTS I
LIST OF FIGURES XII
LIST OF CHARTS XXVII
EXECUTIVE SUMMARY 1
EUROPE INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
PROCEDURES INCLUDED 12
MARKETS INCLUDED 13
VERSION HISTORY 14
RESEARCH METHODOLOGY 15
Step 1: Project Initiation & Team Selection 15
Step 2: Prepare Data Systems and Perform Secondary Research 18
Step 3: Preparation for Interviews & Questionnaire Design 20
Step 4: Performing Primary Research 21
Step 5: Research Analysis: Establishing Baseline Estimates 23
Step 6: Market Forecast and Analysis 24
Step 7: Identify Strategic Opportunities 26
Step 8: Final Review and Market Release 27
Step 9: Customer Feedback and Market Monitoring 28

IMPACT OF COVID-19 ON THE EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET

2.1 INTRODUCTION 29
2.1.1 Treatable Population and the COVID-19 Virus 30
2.1.2 Market Specifics 30
2.2 COUNTRY PROFILES 32
2.3 ANALYSIS BY MARKET SEGMENT 33
2.3.1 Best Case Scenario 33
2.3.2 Base Case Scenario 37
2.3.3 Worst Case Scenario 41

DISEASE OVERVIEW

3.1 BASIC ANATOMY 46
3.2 DISEASE TREATMENTS AND DIAGNOSTICS 48
3.2.1 General Diagnostics 48
3.2.2 Coronary Artery Disease (CAD) 48
3.2.3 Myocardial Infarction (MI) 49
3.2.4 Angina Pectoris 50
3.3 PATIENT DEMOGRAPHICS 51
3.3.1 General Statistics 51

PRODUCT ASSESSMENT

4.1 INTRODUCTION 53
4.2 PRODUCT PORTFOLIOS 53
4.2.1 Coronary Stent Market 53
4.2.2 Coronary Balloon Catheter Market 56
4.2.3 Balloon-Inflation Device Market 59
4.2.4 Interventional Coronary Catheter Market 60
4.2.5 Interventional Coronary Guidewire Market 63
4.2.6 Coronary Embolic Protection Device Market 66
4.2.6.1 Saphenous Vein Grafts 66
4.2.6.2 Protection Mechanism 66
4.2.6.2.1 Filter Basket 66
4.2.6.2.2 Distal Balloon Occlusion 67
4.2.7 Coronary Atherectomy Device Market 68
4.2.7.1 Laser Atherectomy 68
4.2.7.2 Directional Coronary Atherectomy (DCA) 68
4.2.7.3 Mechanical Atherectomy 69
4.2.8 Coronary Thrombectomy Device Market 70
4.2.9 Coronary Chronic Total Occlusion Device Market 71
4.2.10 Coronary Introducer Sheath Market 73
4.2.10.1 Femoral Approach 73
4.2.10.2 Radial/Brachial Approach 74
4.2.11 Coronary Vascular Closure Device Market 76
4.2.12 Diagnostic Coronary Catheter & Guidewire 78
4.2.13 Coronary Intravascular Ultrasound Market 80
4.2.14 Optical Coherence Tomography Market 82
4.2.15 Hemostasis Valve Market 84
4.3 REGULATORY ISSUES AND RECALLS 85
4.3.1 Abbott 85
4.3.1.1 Coronary Stent 85
4.3.1.2 Coronary Balloon Catheter 85
4.3.1.3 Introducer Sheath 87
4.3.1.4 Coronary Vascular Closure Device 87
4.3.2 Boston Scientific 88
4.3.2.1 Coronary Stent 88
4.3.2.2 Coronary Balloon Catheter 88
4.3.2.3 Balloon-Inflation Device 89
4.3.2.4 Interventional Coronary Catheter 89
4.3.2.5 Interventional Coronary Guidewire 90
4.3.2.6 Coronary Thrombectomy 91
4.3.3 Cardinal Health 92
4.3.3.1 Coronary Stent 92
4.3.4 Medtronic 93
4.3.4.1 Coronary Stent 93
4.3.4.2 Introducer Sheath 93
4.3.4.3 Coronary Balloon Catheter 94
4.3.4.4 Interventional Coronary Catheter 94
4.3.5 Merit Medical Systems 96
4.3.5.1 Introducer Sheath 96
4.3.7 Terumo 97
4.3.7.1 Interventional Coronary Catheter 97
4.3.7.2 Introducer Sheath 98
4.3.7.3 Coronary Vascular Closure Device 99
4.4 CLINICAL TRIALS 100
4.4.1 Coronary Stent 101
4.4.1.1 Abbott 101
4.4.1.2 Boston Scientific 102
4.4.1.3 Medtronic 103
4.4.2 Coronary Balloon Catheter 107
4.4.2.1 Boston Scientific 107
4.4.2.2 Medtronic 107
4.4.3 Balloon Inflation Device 108
4.4.3.1 Central Arkansas Veterans Healthcare System 108
4.4.3.2 Guy’s and St Thomas’ NHS Foundation Trust 108
4.4.4 Interventional Coronary Catheter 109
4.4.4.1 Medtronic 109
4.4.4.2 Philips 111
4.4.5 Coronary Embolic Protection Device 112
4.4.5.1 Icahan School of Medicine at Mount Sinai 112
4.4.5.2 Javelin Medical 112
4.4.5.3 Keystone Heart 113
4.4.5.4 Microvention-Terumo, Inc 113
4.4.6 Coronary Atherectomy Device 114
4.4.6.1 Segeberger Kliniken GmbH 114
4.4.6.2 Spectranetics Corporation 114
4.4.7 Coronary Vascular Closure Device 115
4.4.7.1 Cordis Corporation 115
4.4.7.2 Medtronic 116
4.4.7.3 Terumo Medical Corporation 116
4.4.8 Coronary Intravascular Ultrasound 117
4.4.8.1 Aarhhus University Hospital Skejby 117
4.4.8.2 European Cardiovascular Research Institute 117
4.4.9 Coronary Optical Coherence Tomography 118
4.4.9.1 Columbia University 118

EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW

5.1 INTRODUCTION 119
5.2 CURRENCY EXCHANGE RATE 121
5.3 MARKET OVERVIEW 122
5.4 TREND ANALYSIS BY SEGMENT 130
5.5 DRIVERS AND LIMITERS 134
5.5.1 Market Drivers 134
5.5.2 Market Limiters 135
5.6 COMPETITIVE MARKET SHARE ANALYSIS 138
5.7 MERGERS AND ACQUISITIONS 145
5.8 COMPANY PROFILES 147
5.8.1 Abbott 147
5.8.2 Asahi Intecc 149
5.8.3 Boston Scientific 150
5.8.4 Cardinal Health 151
5.8.4.1 Cordis (Cardinal Health) 152
5.8.5 Cardiovascular Systems Inc. 153
5.8.6 Cook Medical 154
5.8.7 Medtronic 155
5.8.8 Merit Medical Systems 157
5.8.9 Penumbra 158
5.8.10 Philips 159
5.8.11 Teleflex 161
5.8.12 Terumo 163
5.9 SWOT ANALYSIS 165
5.9.1 Abbott 166
5.9.2 Asahi Intecc 167
5.9.3 Boston Scientific 168
5.9.4 Cardinal Health 169
5.9.5 Cardiovascular Systems Inc. 170
5.9.6 Cook Medical 171
5.9.7 Medtronic 172
5.9.8 Merit Medical Systems 173
5.9.9 Penumbra 174
5.9.10 Philips 175
5.9.11 Teleflex 176
5.9.12 Terumo 177

COUNTRY PROFILES

6.1 INTRODUCTION 178
6.1.1 Population 178
6.1.2 GDP Per Capita 178
6.1.3 Price Index 178
6.2 GERMANY 179
6.3 FRANCE 180
6.4 UNITED KINGDOM 181
6.5 ITALY 182
6.6 SPAIN 183
6.7 BENELUX 184
6.8 SCANDINAVIA 185
6.9 AUSTRIA 186
6.10 SWITZERLAND 187
6.11 PORTUGAL 188

PROCEDURE NUMBERS

7.1 PROCEDURES 189
7.1.1 Angiography Procedures 192
7.1.1.1 Angiography Procedures by Approach 195
7.1.2 Angioplasty/PCI Procedures 196
7.1.2.1 Angioplasty/PCI Procedures by Approach 199
7.1.3 SVG Procedures 200
7.1.4 FFR Procedures 203
7.1.5 IVUS Procedures 206
7.1.6 OCT Procedures 209
7.1.7 Catheterization Procedures 212

CORONARY STENT MARKET

8.1 INTRODUCTION 215
8.2 MARKET OVERVIEW 217
8.3 MARKET ANALYSIS AND FORECAST 222
8.3.1 Total Coronary Stent Market 222
8.3.2 Drug-Eluting Stent Market 229
8.3.3 Bare-Metal Stent Market 237
8.4 DRIVERS AND LIMITERS 244
8.4.1 Market Drivers 244
8.4.2 Market Limiters 244
8.5 COMPETITIVE MARKET SHARE ANALYSIS 247

CORONARY BALLOON CATHETER MARKET

9.1 INTRODUCTION 252
9.2 MARKET OVERVIEW 254
9.3 MARKET ANALYSIS AND FORECAST 259
9.3.1 Total Coronary Balloon Catheter Market 259
9.3.2 PTCA Balloon Catheter Market 266
9.3.3 Drug-Eluting Balloon Market 273
9.3.4 Specialty Balloon Catheter Market 280
9.4 DRIVERS AND LIMITERS 287
9.4.1 Market Drivers 287
9.4.2 Market Limiters 287
9.5 COMPETITIVE MARKET SHARE ANALYSIS 290

INTERVENTIONAL CORONARY CATHETER MARKET

10.1 INTRODUCTION 294
10.2 MARKET ANALYSIS AND FORECAST 295
10.3 DRIVERS AND LIMITERS 302
10.3.1 Market Drivers 302
10.3.2 Market Limiters 302
10.4 COMPETITIVE MARKET SHARE ANALYSIS 305

INTERVENTIONAL CORONARY GUIDEWIRE MARKET

11.1 INTRODUCTION 309
11.2 MARKET ANALYSIS AND FORECAST 310
11.3 DRIVERS AND LIMITERS 317
11.3.1 Market Drivers 317
11.3.2 Market Limiters 318
11.4 COMPETITIVE MARKET SHARE ANALYSIS 320

CORONARY EMBOLIC PROTECTION DEVICE MARKET

12.1 INTRODUCTION 325
12.1.1 Saphenous Vein Grafts 325
12.1.2 Protection Mechanism 326
12.2 MARKET ANALYSIS AND FORECAST 327
12.3 DRIVERS AND LIMITERS 334
12.3.1 Market Drivers 334
12.3.2 Market Limiters 335
12.4 COMPETITIVE MARKET SHARE ANALYSIS 337

CORONARY ATHERECTOMY DEVICE MARKET

13.1 INTRODUCTION 340
13.2 MARKET OVERVIEW 341
13.3 MARKET ANALYSIS AND FORECAST 346
13.3.1 Total Coronary Atherectomy Device Market 346
13.3.2 Mechanical Atherectomy Device Market 353
13.3.3 Laser Atherectomy Device Market 360
13.4 DRIVERS AND LIMITERS 367
13.4.1 Market Drivers 367
13.4.2 Market Limiters 368
13.5 COMPETITIVE MARKET SHARE ANALYSIS 370

For a Full Table of Contents, please contact iData.
The Interventional Cardiology Market Report Suite| Europe | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Abbott
  • ACIST Medical Systems
  • Acrostak
  • Alvimedia
  • AndraTec
  • AngioDynamics
  • Argon Medical
  • Asahi Intecc
  • B. Braun
  • Balton Medical
  • Becton Dickinson
  • Biosensors
  • Biotronik
  • Boston Scientific
  • Cardinal Health
  • Cardiovascular Systems Inc.
  • Cardiovovum
  • Cardiva
  • CeloNova BioSciences
  • Comed
  • Contego Medical
  • Cook Medical
  • Elixir Medical Corporation
  • Eucatech
  • Euocor
  • Galt Medical
  • Hexacath
  • iVascular
  • Kardia
  • Kimal
  • Medcomp
  • Medtronics
  • Meril Life Sciences
  • Merit Medical
  • Opsens
  • OrbusNeich
  • Philips
  • Rontis
  • Simeks Medical
  • SMT
  • Stentys
  • Teleflex
  • Terumo
  • Vascular Perspectives
  • Vasorum
  • Wellinq

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology